or
forgot password

An Intervention to Improve Outcomes in Patients With Advanced Cancer


Phase 3
21 Years
N/A
Open (Enrolling)
Both
Cancer

Thank you

Trial Information

An Intervention to Improve Outcomes in Patients With Advanced Cancer


Inclusion Criteria:



- primary diagnosis of advanced lung, GI, Head & Neck, and Lung cancers

- post-surgical/or post-biopsy with physician's order for cancer treatment

- age 21 years or older

- lives within 50 of Yale New Haven Hospital

- has 2 or more co-morbid conditions

- has an emotional distress thermometer score of greater than or equal to 4-

Exclusion Criteria:

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

Uncertainty

Outcome Description:

The MUIS-C contains 23 Likert scale items with scores that range from 1= strongly disagree to 5= strongly agree.

Outcome Time Frame:

1 month post baseline

Safety Issue:

No

Principal Investigator

Ruth McCorkle, RN, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Yale University

Authority:

United States: Federal Government

Study ID:

0909005722

NCT ID:

NCT01272024

Start Date:

September 2009

Completion Date:

July 2012

Related Keywords:

  • Cancer
  • clinical trial
  • symptom education
  • advanced cancer
  • Neoplasms

Name

Location
Yale New Haven Hospital/Smilow Cancer Hospital New Haven, Connecticut  06510